The immunohistochemical outcomes have shown that TAA controls experienced severe liver cirrhosis, fibrosis, and cellular proliferation, as shown by increased concentrations of α-SMA and PCNA proteins in their liver tissue. The gene discussed is ACTA1; the disease is cirrhosis of liver.